# From integrative OncoGenomics (intOGen) platform   https://www.intogen.org/
PIK3CA
KMT2C
KMT2D
EP300
FBXW7
TP53
FAT1
ERBB2
NOTCH1
KRAS
STK11
CDK12
CASP8
PTEN
MED12
MAPK1
ERBB3
ARID1A
NFE2L2
RB1
BAP1
LATS1
SMAD4
HLA-B
POLE
KLF5
COL1A1
POLQ
IFNGR1
EIF3E
TGFBR2
HLA-A
AKT1
NF2
FAS
SPEN
SRSF2
PBRM1
B2M
MAP3K1
NSD1
CBFA2T3
STIL
CLIP1
SIRPA
# Biewenga P, Buist M R, Moerland P D, et al. Gene expression in early stage cervical cancer[J]. Gynecologic oncology, 2008, 108(3): 520-526.
BANF1
LARP7
SCAMP1
CUEDC1
PEBP1
# Steenbergen R D M, Kramer D, Braakhuis B J M, et al. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia[J]. Journal of the National Cancer Institute, 2004, 96(4): 294-305.
TSLC1
# Heselmeyer-Haddad K, Sommerfeld K, White N M, et al. Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancer[J]. The American journal of pathology, 2005, 166(4): 1229-1238.
TERC
# Yi Y, Fang Y, Wu K, et al. Comprehensive gene and pathway analysis of cervical cancer progression[J]. Oncology Letters, 2020, 19(4): 3316-3332.
KIF11
KIF15
KIF23
KIF4A
KIF14
BUB1B
BUB1
CCNA2
CCNB1
CDK1
GBP1
RHOA
IFI44L
IFIT3
IFIF1
IFIF5
IFI44
IFIT2
IFI6
IRF7
STAT1
CXCL10
HGF
IGF1
KIT
FN1
CXCL12
CCND1
VEGFA
CXCL8
CXCL11
CXCL4
ITGB1
ITGA1
MAPK12
FOS
# Lao G, Liu P, Wu Q, et al. Mir-155 promotes cervical cancer cell proliferation through suppression of its target gene LKB1[J]. Tumor Biology, 2014, 35(12): 11933-11938.
LKB1
PAX1
WT1
SOX1
NKX6-1
LMX1A
ONECUT1
# Xu W, Xu M, Wang L, et al. Integrative analysis of DNA methylation and gene expression identified cervical cancer-specific diagnostic biomarkers[J]. Signal transduction and targeted therapy, 2019, 4(1): 55.
RAB3C
GABRA2
ZNF257
SLC5A8
# Wu X, Peng L, Zhang Y, et al. Identification of key genes and pathways in cervical cancer by bioinformatics analysis[J]. International journal of medical sciences, 2019, 16(6): 800.
CCNE1
CDKN3
SOX4
MDC1
SERPINB5
CST6
ORAOV1
CYB5D2
TSPO
TOP2A
PCNA
BIRC5
MAD2L1
UHRF1
# Narayan G, Bourdon V, Chaganti S, et al. Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: identification of candidate amplified and overexpressed genes[J]. Genes, Chromosomes and Cancer, 2007, 46(4): 373-384.
EPHB1
CDCA8
AIM2
RFC4
MUC4 
HRASLS
SKP2
CENTD3
PTK2
RECQL4 
MMP1
MMP13
ABCC3
SMARCA4
LIG1
UBE2C 
SMC1L1
TMSNB
CSAG2
# Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer[J]. Nature, 2017, 543(7645): 378.
SHKBP1
# Deng, H., Guan, X., Gong, L. et al. CBX6 is negatively regulated by EZH2 and plays a potential tumor suppressor role in breast cancer. Sci Rep 9, 197 (2019). https://doi.org/10.1038/s41598-018-36560-4
CBX6
# Jacobus J. W, Rauf S, Hatta M, Natsir R, Massi M. N, Cangara M. H, Masadah R, Pattelongi I. J, Salim J. YinYang 1 (YY1) and P53 Gene Expression Analysis in Cervical Cancer and Its Relationship with Cancer Staging. Biomed Pharmacol J 2020;13(3).
YY1
# Xia L, Su X, Shen J, et al. ANLN functions as a key candidate gene in cervical cancer as determined by integrated bioinformatic analysis[J]. Cancer management and research, 2018, 10: 663.
ANLN
# Huisman C, Wisman G B A, Kazemier H G, et al. Functional validation of putative tumor suppressor gene C13ORF18 in cervical cancer by artificial transcription factors[J]. Molecular oncology, 2013, 7(3): 669-679.
C13ORF18
# Wu, B., Xi, S. Bioinformatics analysis of differentially expressed genes and pathways in the development of cervical cancer. BMC Cancer 21, 733 (2021). https://doi.org/10.1186/s12885-021-08412-4
NUSAP1
KIF2C
NDC80
ASPM
KIF20A
MCM2
CHEK1
BLM
RMI2
EXO1
PSCA
KNTC1
CDC45
GINS2
TNFAIP6
CXCL5
CDA
CENPF